Last updated: April 23, 2024
Sponsor: Children's Hospital Medical Center, Cincinnati
Overall Status: Active - Recruiting
Phase
1/2
Condition
N/ATreatment
Hyperpolarized 129 Xenon
Clinical Study ID
NCT02272049
2014-5279
IND 123577
Ages > 6 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Ages 6 and up
- Participant must be able to hold breath for up to 16 seconds
Exclusion
Exclusion Criteria:
- History of heart defect
- Pregnancy or positive pregnancy test
- History of uncontrolled asthma defined for this study as requiring use of rescueinhaler ≥ 2 times in past month
- Symptoms of respiratory infection (loose or productive cough or wheeze), chesttightness, or sinus infection within past week
- Baseline oximetry at MRI visit of less than 95% on room air or less than 95% on apreviously prescribed dosage of oxygen delivered by nasal cannula
- Participant is claustrophobic and unable to tolerate the imaging.
- Standard MRI exclusions (metal, implants)
Study Design
Total Participants: 300
Treatment Group(s): 1
Primary Treatment: Hyperpolarized 129 Xenon
Phase: 1/2
Study Start date:
December 01, 2014
Estimated Completion Date:
August 31, 2027
Study Description
Connect with a study center
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.